Tauschmann M, Thabit H, Bally L et al. Closed-loop insulin delivery in sub- optimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet 2018;392(10155):1321-9. https://doi.org/10.1016/S0140-6736(18)31947-0 Collyns OJ, Meier RA, Betts ZL et al. Improved glycemic outcomes with Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: results from a randomized crossover trial comparing automatediInsulin delivery with predictive low glucose suspend in people with type 1 diabetes.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Robert EJ Ryder
The effect of sodium-glucose link transporter 2 inhibitors on heart failure end points in people with type 2 diabetes mellitus: a systematic review and meta-analysis | British Journal of Diabetes
Authors Thomas Simon James Crabtree University Hospitals of Derby and Burton NHS Trust; University of Nottingham Robert EJ Ryder Sandwell and West Birmingham Hospitals NHS Trust DOI: https://doi.org/10.15277/bjd.2021.307 Keywords: Diabetes, Type 2, Heart Failure, SGLT-2, CVOT Abstract Introduction: Type 2 diabetes is a condition which is frequently associated with macrovascular complications. Sodium-glucose linked transporter-2 inhibitors (SGLT2i) have been demonstrated to improve composite...
Effect of empagliflozin on albuminuria, eGFR and serum creatinine: updated results from the ABCD nationwide empagliflozin audit Thomas SJ Crabtree, Alex Bickerton, Jackie Elliott, Rajeev Raghavan, Dennis Barnes, Siva Sivappriyan, Suzanne Phillips, Alison Evans, Devesh Sennik, Anurita Rohilla, Ian Gallen, Robert EJ Ryder, ABCD Empagliflozin Audit Contributors - Abstract Introduction: Evidence from phase III and the EMPA-REG OUTCOME trials have demonstrated improvements in renal endpoints with...
An audit of people admitted to hospital with diabetes and coronavirus (SARS-CoV-2): data collection methods. The Association of British Clinical Diabetologists (ABCD) Nationwide Audit
An audit of people admitted to hospital with diabetes and coronavirus (SARS-CoV-2): data collection methods.
Diabetes medications with cardiovascular protection: the likelihood of benefit from combination therapy increases further following new evidence during 2020
Ryder REJ, DeFronzo RA. Diabetes medications with cardiovascular protection in the wake of EMPA-REG OUTCOME™: the optimal combination may be metformin, pioglitazone and empagliflozin. Br J Diabetes Vasc Dis 2015; 15:151–4. http://dx.doi.org/10.15277/bjdvd.2015.045 Ryder REJ, DeFronzo RA. Diabetes medications with cardiovascular protection – what now after LEADER®? Could metformin, pioglitazone, empagliflozin and liraglutide complement each other to save lives? Br J Diabetes 2016;16:103–6.
From the Pulpit: In support of peaceful protests
From the Pulpit: In support of peaceful protests × You have run out of free articles. You can support our newsroom by joining at our lowest rate! Already a subscriber? Log in or Activate your account. Loading&hellp; {{html}} Thanks for being a subscriber. Sorry, your subscription does not include this content. Please call 855.264.2511 to upgrade your subscription. × Sign Up Today and Support Local Journalism Enjoy more articles from Bloomington's Most Trusted Information Source.
The United Kingdom's first NHS Endobarrier service for advanced diabesity: 1-year outcomes for all 62 treated patients
The EndoBarrier Gastrointestinal Liner with Delivery System: instructions for use. GID part number 50-10-00552 Rev N. http://gidynamics.com/wp-content/uploads/2017/09/50-10-00552-Rev-N-IFU-EB-GI-Liner-with-Delivery-System.pdf (accessed 10 September 2019) de Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal–jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg 2013;23:1354–60. https://doi.org/10.1007/s11695-013-0921-3 Betzel B, Homan J, Aarts EO, et al.
From the Pulpit: Mindful maintenance
I can usually keep my attention on positive, constructive activities. Maybe it’s partly a personality trait, although there’s likely some luck and privilege involved, too. I hope there’s skill to it as well, because if there’s an element of skill to being happy or at least content — that gives us some control. But it’s been harder lately, taking more conscious effort.
From the Pulpit: Mindful maintenance
I can usually keep my attention on positive, constructive activities. Maybe it’s partly a personality trait, although there’s likely some luck and privilege involved, too. I hope there’s skill to it as well, because if there’s an element of skill to being happy or at least content – that gives us some control. But it’s been harder lately, taking more conscious effort.
Young Asian men with diabetes have the highest risk for acute coronary events: retrospective cohort analyses
The city of Birmingham (UK) has a varied representation from all ethnic communities. The present study is a retrospective cohort analysis of coronary heart disease events (acute coronary syndrome, acute myocardial infarction) in patients with type II diabetes among the three main ethnic groups (Asian, Afro-Caribbean, Caucasian) presenting to the hospital cardiology unit over a six-year period.
From the Pulpit: Let Christmas come again
Getting into the spirit of the season has been difficult this year. There’s so much uncertainty and ugliness in the world. Meanness and willful ignorance are en vogue; the chaos in our national politics and the hostility with which we so easily engage are overwhelming.The most helpful thing I’ve found to deal with it all is that observing Christmas cannot be reduced to a single historical instance.
Maintenance of efficacy after duodenal- jejunal bypass liner explantation in the first NHS EndoBarrier service
GI Dynamics. The EndoBarrier GI Liner with Delivery System: instructions for use. GID part number 50-10-00552 Rev N. http://gidynamics.com/wp-content/uploads/2017/09/50-10-00552-Rev-N-IFU-EB-GI-Liner-with-Delivery-System.pdf (accessed 20 September 2017) Betzel B, Homan J, Aarts EO, et al. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study. Surg Endosc 2017;31:2881–91.
What now on the CANVAS of diabetes medications with cardiovascular protection? Could metformin, pioglitazone, SGLT2 inhibitors and liraglutide complement each other to save lives? | Ryder | British Journal of Diabetes
The CANVAS Program (CANagliflozin cardioVascular Assessment Study). The slide set used at the presentation of the CANVAS study results on June 12th 2017 during the 77th Scientific Sessions of the American Diabetes Association in San Diego, USA. http://www.georgeinstitute.org/sites/default/files/canvas-study-results-ada-2017.pdf (accessed 3 July 2017) Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med 2017.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Robert EJ
Contact Robert EJ, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack